{"id":3177,"date":"2023-09-13T08:32:59","date_gmt":"2023-09-13T06:32:59","guid":{"rendered":"https:\/\/slovhep.sk\/51st-may-hepatology-days-2024"},"modified":"2023-09-13T08:32:59","modified_gmt":"2023-09-13T06:32:59","slug":"51st-may-hepatology-days-2024","status":"publish","type":"post","link":"https:\/\/slovhep.sk\/en\/51st-may-hepatology-days-2024","title":{"rendered":"51st May Hepatology Days 2024"},"content":{"rendered":"<p><strong>Date from:<\/strong> 2024-05-22 00:00:00<\/p>\n<p><strong>Date to:<\/strong> 2024-05-24 00:00:00<\/p>\n<p>We invite you to the 51st May Hepatology Days, which will take place at Hotel Patria at \u0160trbsk\u00e9 Pleso from 22 to 24 May 2024.  <\/p>\n<p>&nbsp;<\/p>\n<p>The congress is the most important event in the field of Hepatology in Slovakia and has much to offer not only hepatologists but also gastroenterologists, internists, general practitioners, surgeons, and other specialties. It will also include a nursing section (23 May 2024) and practical workshops dedicated to ultrasound and elastography in hepatology. <\/p>\n<p>We invite you to participate actively; <strong>the deadline for abstract submission is 31 March 2024<\/strong>.<\/p>\n<p>Preliminary programme:<\/p>\n<p><strong>22.5.2024<\/strong><\/p>\n<p><strong>9.00 \u2013 11.30 Pre-congress activities<\/strong><\/p>\n<p><strong>9.00 \u2013 10.00 Young hepatologists<\/strong><\/p>\n<p><strong>10.15 \u2013 11.30 Research group <\/strong><\/p>\n<p>Introduction<\/p>\n<p>Adamcov\u00e1 Sel\u010danov\u00e1 S., Havaj D.: SIRIUS<\/p>\n<p>\u017dilin\u010danov\u00e1 D., \u0160ulejov\u00e1 K.: HEGITO registry<\/p>\n<p>Miscellaneous<\/p>\n<p>Discussion<\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>9.00 -11.30 Teaching area \u2013 abdominal ultrasonography and elastography <\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>12.00 \u2013 13.00 Lunch <\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>13.00 \u2013 13.15 Opening<\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>13.20 \u2013 14.20 Block 1. Map of steatotic liver disease in Slovakia, present and future (Koller T., R\u00e1c M., Pr\u0161o M.) <\/strong><\/p>\n<p>13.21 \u2013 13.31 Koller T., Adamcov\u00e1 Sel\u010danov\u00e1 S., Skladan\u00fd \u013d. (Bratislava, Bansk\u00e1 Bystrica): Epidemiological map of steatotic liver disease in Slovakia <\/p>\n<p>13.32 \u2013 13.42 Havaj D., Jursov\u00e1 X., Szantov\u00e1 M., Skladan\u00fd \u013d., Koller T. (Bansk\u00e1 Bystrica, Bratislava): Screening for advanced liver fibrosis in steatosis, comparison of methods in real-world practice.<\/p>\n<p>13.43 \u2013 13.58 Ku\u017eela L. (Bratislava): Lifestyle change in the management of steatotic liver disease<\/p>\n<p>13.59 \u2013 14.14 R\u00e1c M. (Nitra): Pharmacological treatment of steatotic liver disease\u2014will it be for everyone?<\/p>\n<p>14.15 \u2013 14.20 Discussion<\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>14.25 \u2013 14.45 State of the art 1. (Dra\u017eilov\u00e1 S., Jar\u010du\u0161ka P., Skladan\u00fd \u013d.)  <\/strong><\/p>\n<p><strong>\u0160perl J. (Prague, Czech Republic): TBA<\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>14.45 \u2013 15.45 Block 2. Liver cirrhosis and its complications<\/strong> <strong>(Skladan\u00fd \u013d., Jar\u010du\u0161ka P., Havaj D.)<\/strong><\/p>\n<p>14.46 \u2013 14.54 Hrn\u010d\u00e1r M. (Bansk\u00e1 Bystrica): Liver injury (DILI) caused by new drugs for hepatocellular carcinoma<\/p>\n<p>14.55 \u2013 15.03 \u0160af\u010d\u00e1k D. (Ko\u0161ice): What have we learned about liver tumours in Slovakia from registries?<\/p>\n<p>15.04 \u2013 15.12 Strachan J., Mol\u010dan P. (Bansk\u00e1 Bystrica): Endoscopic hepatology and cirrhosis<\/p>\n<p>15.13 \u2013 15.21 Vrbov\u00e1 P., Koller T. (Bratislava): Calprotectin in liver cirrhosis?<\/p>\n<p>15.22 \u2013 15.30 Gazda J., Jani\u010dko M., Dra\u017eilov\u00e1 S., Jar\u010du\u0161ka P. (Ko\u0161ice): Speech analysis and hepatic encephalopathy<\/p>\n<p>15.30 \u2013 15.45 Discussion<\/p>\n<p>&nbsp;<\/p>\n<p>15.45 \u2013 16.05 Break<\/p>\n<p>&nbsp;<\/p>\n<p><strong>16.05 \u2013 16.50<\/strong> <strong>Symposium supported by Gilead<\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>16.55 \u2013 17.15 State of the art 2. (Jar\u010du\u0161ka P., Oltman M.) <\/strong><\/p>\n<p><strong>Skladan\u00fd \u013d. (Bansk\u00e1 Bystrica): 10 years of the cirrhosis registry  <\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>17.15 \u2013 18.15 Block 3. Working Group Block: Young Hepatologists (Nos\u00e1kov\u00e1 L., \u017dilin\u010danov\u00e1 D., Va\u017eanov\u00e1 D.) <\/strong><\/p>\n<p>17.16 \u2013 17.28 Havaj D. (Bansk\u00e1 Bystrica): Cirrhosis-associated immune dysfunction<\/p>\n<p>17.29 \u2013 17.41 \u0160m\u00edd V. (Prague): MASLD and associated extrahepatic diseases\u2014wolf in sheep\u2019s clothing?<\/p>\n<p>17.42 \u2013 17.54 Schnierer M. (Martin): Portal hypertension from a gastroenterologist\u2019s perspective<\/p>\n<p>17.55 \u2013 18.07 Kov\u00e1\u010dov\u00e1 K. (\u0160a\u013ea): Cooperation between the hepatologist and the general practitioner in managing a patient with hepatopathy<\/p>\n<p>18.07 \u2013 18.15 Discussion<\/p>\n<p>&nbsp;<\/p>\n<p>18.15 \u2013 18.25 Break<\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>18.25 \u2013 18.55 Symposium supported by Roche  <\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>19.00 -19.30 Plenary meeting<\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>20.00 Dinner + ceremonial presentation of SHS awards<\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>23.5.2024<\/strong><\/p>\n<p><strong>8.30 -11.00 Teaching area: Abdominal ultrasonography and elastography <\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>11.00 \u2013 12.00 Poster session (Gregu\u0161ov\u00e1 A., \u017dilin\u010danov\u00e1 D.)<\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>12.00 \u2013 13.00 Lunch<\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>13.00 \u2013 14.00 Block 4. Alcohol-related liver disease (Sz\u00e1ntov\u00e1 M., Jani\u010dko M., Vrbov\u00e1 P.) <\/strong><\/p>\n<p>13.01 \u2013 13.13 Sz\u00e1ntov\u00e1 M. (Bratislava): ALD screening in the context of the new MASLD (MetAld) definition<\/p>\n<p>13.14 \u2013 13.26 Gazda J. (Ko\u0161ice): Pitfalls of non-invasive diagnosis of severe alcoholic hepatitis.<\/p>\n<p>13.27 \u2013 13.39 \u0160ulejov\u00e1 K., Skladan\u00fd \u013d. (Bansk\u00e1 Bystrica): What is new in the treatment of severe alcohol-associated hepatitis? <\/p>\n<p>13.40 \u2013 13.52 Chv\u00e1la \u013d. (Bansk\u00e1 Bystrica): Psychological assessment of liver transplant candidates <\/p>\n<p>13.52 \u2013 14.00 Discussion<\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>14.05 \u2013 15.05<\/strong> <strong>Block 5. Block of the Czech Hepatology Society<\/strong> <\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>15.10 \u2013 16.10 Symposium supported by PRO.MED.CS Praha a.s.<\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>16.10 \u2013 16.30<\/strong><strong> Break<\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>16.30 -17.25<\/strong><\/p>\n<p><strong>Block 6. Steatotic liver disease through the eyes of a (non-)hepatologist (Dra\u017eilov\u00e1 S., Makara P., Schroner Z., Stan\u00edkov\u00e1 D.) <\/strong><\/p>\n<p>16.31 \u2013 16.43 Stan\u00edkov\u00e1 D., Kosn\u00e1\u010dov\u00e1 J., \u010cierna I., Vitariu\u0161ov\u00e1 E., Stan\u00edk J. (Bratislava): Steatotic liver disease in children with early-onset obesity<\/p>\n<p>16.44 \u2013 16.56 Schroner Z. (Ko\u0161ice): Steatotic liver disease through the eyes of a diabetologist<\/p>\n<p>16.57 \u2013 17.09 Keher I., \u0160kuta R., Dobrovodsk\u00fd A. (Trnava): Metabolic-bariatric surgery\u2014a path to long-term weight loss and improvement of associated diseases<\/p>\n<p>17.10 \u2013 17.25 Panel discussion<\/p>\n<p>&nbsp;<\/p>\n<p><strong>17.30 \u2013 18.30 Symposium supported by Novo Nordisk<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><strong>18.30 \u2013 18.45<\/strong><strong> Break<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><strong>18.45 \u2013 19.15<\/strong>  <strong>Symposium supported by Abbvie<\/strong><\/p>\n<p><strong>19.15 \u2013 19.30 Lecture supported by Sanofi<\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>20.00 Dinner + award for the best papers<\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>24.5.2023<\/strong><\/p>\n<p><strong>9.00 \u2013 10.00 <\/strong><strong> Block 7. <\/strong><strong>Viral hepatitis (Kristian P., Oltman M., \u0160ulejov\u00e1 K.)<\/strong><\/p>\n<p>9.01 \u2013 9.11 \u017dilin\u010danov\u00e1 D., Skladan\u00fd \u013d. (Bansk\u00e1 Bystrica): Neutrophil-to-lymphocyte ratio in patients with viral aetiology of ACLD compared with other causes: analysis of data from the RH7 registry <\/p>\n<p>9.12 \u2013 9.22 Kristian P., Hockickov\u00e1 I., Jurek J., Lami F., Rov\u0148\u00e1kov\u00e1 A. (Ko\u0161ice): Options for using quantitative HBsAg determination in clinical practice<\/p>\n<p>9.23 \u2013 9.33 Oltman M. (Bratislava): HCC after elimination of chronic hepatitis C<\/p>\n<p>9.34 \u2013 9.44 Hockickov\u00e1 I., Lami F., Hockicko J., Jurek J., Kristian P. (Ko\u0161ice): First experience with routine diagnostics of hepatitis D<\/p>\n<p>9.45 \u2013 9.55 Sekula J., Parali\u010dov\u00e1 Z. (Ko\u0161ice): Hepatitis E at the Clinic of Infectious Diseases and Travel Medicine in Ko\u0161ice<\/p>\n<p>9.55 \u2013 10.00 Discussion<\/p>\n<p>&nbsp;<\/p>\n<p><strong>10.05 \u2013 10.35 Symposium supported by W\u00f6rwag Pharma <\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><strong>10.35- 11.00 Break<\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>11.00 -12.00 Block 8.<\/strong><strong> Various (\u017digrai M., Parali\u010dov\u00e1 Z., Martinkov\u00e1 D.)<\/strong><\/p>\n<p><strong> <\/strong><\/p>\n<p><strong>12.05 \u2013 13.05 Block 9. Autoimmune liver diseases (Dra\u017eilov\u00e1 S., Adamcov\u00e1 Sel\u010danov\u00e1 S., Koky T.) <\/strong><\/p>\n<p>12.06 \u2013 12.18 Adamcov\u00e1 Sel\u010danov\u00e1 S. (Bansk\u00e1 Bystrica): Autoimmune hepatitis: treatment management<\/p>\n<p>12.19 \u2013 12.31 Jar\u010du\u0161ka P. (Ko\u0161ice): Autoimmune liver diseases: fertility, pregnancy<\/p>\n<p>12.32 \u2013 12.44 Dra\u017eilov\u00e1 S., Jar\u010du\u0161ka P., Jani\u010dko M., Toporcerov\u00e1 D. (Ko\u0161ice): Our experience with obeticholic acid treatment in patients with PBC (lecture supported by MagnaPharm)<\/p>\n<p>12.45 \u2013 12.57 Brun\u010d\u00e1k M. (Bansk\u00e1 Bystrica): Primary sclerosing cholangitis: management of strictures from a gastroenterologist\u2019s perspective<\/p>\n<p>12.57 \u2013 13.05 Discussion<\/p>\n<p>&nbsp;<\/p>\n<p><strong>13.05 Closing <\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><strong>13.10 Lunch<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>More at:<\/p>\n<p><a href=\"https:\/\/majovky.sk\/\">https:\/\/majovky.sk\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>We invite you to the 51st May Hepatology Days, which will take place at Hotel Patria at \u0160trbsk\u00e9 Pleso from 22 to 24 May 2024. The congress is the most important event in the field of Hepatology in Slovakia and has much to offer not only hepatologists but also gastroenterologists, internists, general practitioners, surgeons, and other specialties. It will also include a nursing section and practical workshops dedicated to ultrasound and elastography in hepatology.    <\/p>\n<p>We invite you to participate actively; <strong>the deadline for abstract submission is 31 March 2024<\/strong>.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/majovky.sk\/\">https:\/\/majovky.sk\/<\/a><\/p>\n","protected":false},"author":2,"featured_media":3178,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[74],"tags":[],"class_list":["post-3177","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events"],"_links":{"self":[{"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/posts\/3177","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/comments?post=3177"}],"version-history":[{"count":0,"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/posts\/3177\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/media\/3178"}],"wp:attachment":[{"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/media?parent=3177"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/categories?post=3177"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/tags?post=3177"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}